Many drugs have been and are being discovered on the basis of natural substances. The task of science is to analyze, optimize and adapt the mechanism of action of natural products or structural analogues to requirements. Methods that have been added to drug discovery in recent years include protein engineering and genome editing. Synergies within the BRAIN group are extremely advantageous:

 

Analyticon Discovery, a BRAIN Group company, is an expert in the research and development of natural products for innovative pharmaceutical, cosmetic and nutritional products.

 

BRAIN Biotech at the Zwingenberg site and Akribion Genomics have expertise in protein engineering and in genome editing respectively.